Who We Insure

Insurance for Life Sciences by Life Sciences Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life sciences markets:

Digital Health Companies

Companies that focus on the convergence of technology and healthcare, developing digital devices, software applications, and online platforms, improving connectivity and spanning a wide range of uses.

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments, digital health products, and devices for healthcare applications.

Medical Device Software Companies

Organizations that develop software solutions for use in union with medical devices and digital health products to enhance functionality and patient outcomes.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Product Development Organizations

Companies offering specialized services in developing, testing, and regulatory approval of life sciences products.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life sciences business by life sciences specialists?

Find an Agent

The Latest in Life Science

Injectable Peptides

Injectable Peptides: Out of the Back Alley and Into the Light?

Spanish explorer Ponce de Leon’s “fountain of youth” is legendary. In St. Augustine, Florida, visitors still flock to a tourist attraction named for that mystical spring, hoping that a drink from the city’s natural waters might turn back their biological clocks.

At least the only consequence of indulging in the Ponce de Leon fantasy is a mouthful of sulfur‑smelling water. Today’s pursuit of the “fountain of youth” carries greater risk. Increasing numbers of consumers are injecting themselves with unapproved peptides based on unsubstantiated claims that these compounds bestow regenerative properties. Many of these products are purchased from online sellers operating outside traditional regulatory oversight, where they have not been tested for either efficacy or safety.

Pharmaceuticals Turn to “Niche‑Busters” for Sustained Growth

The pharmaceutical industry is in the middle of a meaningful shift in research strategy. For many years, research teams pursued blockbuster drugs—compounds designed to treat common conditions shared by large segments of the population. Novel treatments for high blood pressure, diabetes, elevated cholesterol, and other widespread ailments were the gold standard.

AI/MD SaMD

The FDA AI/ML SaMD Framework: What Companies Need to Know Now

In a recent post on this blog, we examined how artificial intelligence (AI) and machine learning (ML) are reshaping the informed consent process in clinical trials—and why the regulatory and legal frameworks surrounding AI in that context are still catching up. That article focused on one corner of the clinical trial lifecycle. This one broadens the lens. Medical devices, and in particular software as a medical device (SaMD) is a different but related category.